Scholar Rock Holding Corp (SRRK)
Scholar Rock Holding Corporation is a biopharmaceutical firm dedicated to discovering and advancing treatments for severe medical conditions by targeting the crucial role of protein growth factor signaling. Their lead therapeutic candidate, Apitegromab, an agent designed to inhibit the activation of latent myostatin, has successfully concluded Phase 3 clinical trials for spinal muscular atrophy (SMA). Another key program, SRK-181, is currently undergoing Phase 1 clinical assessment for tackling cancers that exhibit resistance to established checkpoint inhibitor treatments, including anti-PD-1 or anti-PD-L1 antibody therapies. Beyond these, the company cultivates a robust pipeline of innovative potential therapies, aiming to significantly improve the lives of individuals grappling with various severe ailments, such as neurological muscle conditions, malignancies, and fibrotic disorders. In a strategic partnership, Scholar Rock is collaborating with Gilead Sciences, Inc. to identify and develop targeted inhibitors of transforming growth factor beta (TGF-beta) activation, specifically for addressing fibrotic diseases. Established in 2012, Scholar Rock Holding Corporation operates from its headquarters in Cambridge, Massachusetts.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Scholar Rock Holding Corporation
NASDAQ:SRRKHealthcare · Biotechnology
-0.63%$43.90
AH$43.50-0.91%vs close
Mkt Cap$5.35B
Float109.19M
O/S121.79M
Vol
$ Vol
RVOL
Inst Own-
SI20.3%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$377.94M
Total Assets$404.27M
Free Cash Flow-$300.64M
Debt & Equity
Debt 31%
Equity 69%
Total Debt$108.92M
Total Equity$245.49M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in SRRK's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$404.27M
Liabilities$158.78M
Accounts Receivable$0
Accounts Payable$10.3M
Inventory$0
PP&E (Net)$12.09M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Revenue | $0 | $0 | $0 | $33.19M | $18.82M | $15.4M | $20.49M | $0 | $0 | $379K |
| YoY Growth | - | - | - | 76.4% | 22.2% | -24.8% | - | - | - | - |
| Cost of Revenue | $208.44M | $1.94M | $2.84M | $123.04M | $108.47M | $74.06M | $54.22M | $807K | $669K | $12.48M |
| Gross Profit | -$208.44M | -$1.94M | -$2.84M | -$89.85M | -$89.65M | -$58.66M | -$33.73M | -$807K | -$669K | -$12.1M |
| Gross Margin | - | - | - | -270.7% | -476.5% | -380.8% | -164.6% | - | - | -3192.1% |
| Research and Development | $208.44M | $182.61M | $119.06M | $124.44M | $108.47M | $74.06M | $54.22M | $36.31M | $19.94M | $12.48M |
| Selling, General, and Administrative | $176.21M | $67.5M | $49.4M | $42.62M | $40.27M | $28.22M | $20.82M | $14.38M | $5.08M | $4.11M |
| Other | -$208.44M | $0 | $0 | -$122.54M | -$108.47M | -$74.06M | -$54.22M | -$56K | -$10K | $22K |
| Total Operating Expenses | $176.21M | $250.12M | $168.45M | $44.52M | $40.27M | $28.22M | $20.82M | $50.69M | $25.03M | $16.59M |
| Operating Income (EBIT) | -$384.64M | -$252.05M | -$171.29M | -$134.37M | -$129.92M | -$86.88M | -$54.54M | -$50.69M | -$25.03M | -$16.21M |
| Operating Margin | - | - | - | -404.8% | -690.5% | -564.0% | -266.2% | - | - | -4277.0% |
| Interest Expense | $6.89M | $6.84M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $19K |
| Interest Income | $13.9M | $12.68M | $0 | $0 | $0 | $0 | $0 | $1.42M | $0 | $0 |
| Other Income (Expense) | $6.71M | $5.76M | $5.51M | -$132K | -$1.88M | $395K | $3.54M | $1.37M | $34K | $3K |
| Income Before Tax (EBT) | -$377.94M | -$246.29M | -$165.79M | -$134.5M | -$131.8M | -$86.48M | -$51M | -$49.33M | -$25M | -$16.21M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$44K | $19K |
| Net Income | -$377.94M | -$246.29M | -$165.79M | -$134.5M | -$131.8M | -$86.48M | -$51M | -$49.33M | -$25M | -$16.21M |
| Net Income Margin | - | - | - | -405.2% | -700.5% | -561.5% | -248.9% | - | - | -4276.3% |
| Supplementary Data | ||||||||||
| EPS | -3.29 | -2.47 | -1.99 | -2.21 | -3.59 | -2.77 | -1.80 | -3.15 | -1.40 | -0.91 |
| Diluted EPS | -3.29 | -2.47 | -1.99 | -2.21 | -3.59 | -2.77 | -1.80 | -3.15 | -1.40 | -0.91 |
| Weighted Average OS | 114.70M | 99.84M | 75.98M | 59.61M | 36.71M | 30.73M | 27.54M | 15.66M | 17.91M | 17.91M |
| EBITDA | -$369.39M | -$237.52M | -$162.94M | -$129.48M | -$129.17M | -$85.39M | -$53.24M | -$49.88M | -$24.36M | -$15.63M |
| EBITDA Margin | - | - | - | -390.1% | -686.5% | -554.4% | -259.8% | - | - | -4125.3% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Assets | ||||||||||
| Current Assets | ||||||||||
| Cash and Cash Equivalents | $323.53M | $177.88M | $101.86M | $103.28M | $212.84M | $160.36M | $36.31M | $115.07M | $56.46M | $10.03M |
| Short-Term Investments | $44.04M | $259.4M | $178.08M | $212.09M | $40.16M | $180.67M | $121.14M | $60.58M | $1.5M | $18M |
| Cash and Short-Term Investments | $367.56M | $437.28M | $279.94M | $315.36M | $252.99M | $341.03M | $157.45M | $175.65M | $57.96M | $28.04M |
| Accounts Receivable | $0 | $2.15M | $1.08M | $2.73M | $0 | $0 | $25M | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $17.58M | $0 | $0 | $0 | $12.32M | $0 | $2.72M | $2.3M | $0 | $0 |
| Total Current Assets | $385.15M | $451.17M | $288.19M | $328.02M | $265.32M | $344.4M | $185.17M | $177.94M | $59.2M | $28.5M |
| Long-Term Assets | ||||||||||
| Property, Plant & Equipment Net | $12.09M | $18.41M | $16.02M | $25.93M | $35.01M | $40.38M | $8.62M | $3.19M | $2.18M | $2.43M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $2.4M | $4.07M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $2.5M | $0 | $2.5M | $205K | $205K | $1.5M |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $7.04M | $2.96M | $2.75M | $4.22M | $1.62M | $3.52M | $98K | $0 | $50K | $360K |
| Total Long-Term Assets | $19.13M | $23.76M | $22.84M | $30.14M | $39.13M | $43.9M | $11.21M | $3.4M | $2.44M | $4.29M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $404.27M | $474.92M | $311.04M | $358.17M | $304.44M | $388.31M | $196.38M | $181.34M | $61.64M | $32.78M |
| Liabilities | ||||||||||
| Current Liabilities | ||||||||||
| Accounts Payable | $10.3M | $10.1M | $3.46M | $3.99M | $4.43M | $3.41M | $1.13M | $3.3M | $1.36M | $663K |
| Short-Term Debt | $5.55M | $0 | $1.33M | $0 | $8.98M | $0 | $1.14M | $424K | $641K | $647K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $33.19M | $18.82M | $20.92M | $20.21M | -$641K | -$647K |
| Other Current Liabilities | $19.45M | $0 | $85K | $222K | $3.13M | $15K | $5.25M | $30K | $1.85M | $879K |
| Total Current Liabilities | $55.42M | $46.94M | $32.74M | $36.39M | $64.3M | $42.56M | $32.81M | $31.12M | $5.02M | $3.01M |
| Long-Term Liabilities | ||||||||||
| Long-Term Debt | $99.71M | $50.15M | $48.68M | $49.74M | $48.42M | $24.68M | $0 | $24K | $398K | $1.02M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $33.19M | $46.49M | $42.7M | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$42.72M | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $5K | $9K | $871K | $109.74M | $58.78M |
| Total Long-Term Liabilities | $103.36M | $59.35M | $53.08M | $61.54M | $68.07M | $84.97M | $50.67M | $43.59M | $110.14M | $59.8M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $158.78M | $106.29M | $85.82M | $97.93M | $132.37M | $127.53M | $83.48M | $74.71M | $115.16M | $62.81M |
| Stockholders' Equity | ||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2K | $58.06M |
| Common Stock | $108K | $94K | $76K | $52K | $35K | $34K | $30K | $26K | $4K | $1.47M |
| Retained Earnings | -$1.3B | -$922.72M | -$676.42M | -$510.63M | -$376.13M | -$244.33M | -$157.85M | -$106.85M | -$57.52M | -$32.53M |
| Comprehensive Income & Other | $94K | $160K | $92K | -$884K | -$35K | -$2K | $37K | -$8K | -$2K | -$20K |
| Other Stockholders' Equity | $1.55B | $1.29B | $901.56M | $770.82M | $548.17M | $505.07M | $270.72M | $213.44M | $4M | $1.03M |
| Total Equity | $245.49M | $368.63M | $225.22M | $260.24M | $172.07M | $260.77M | $112.9M | $106.62M | -$53.52M | -$30.03M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $404.27M | $474.92M | $311.04M | $358.17M | $304.44M | $388.31M | $196.38M | $181.34M | $61.64M | $32.78M |
| Supplementary Data | ||||||||||
| Total Debt | $108.92M | $65.13M | $61.82M | $69.4M | $84.47M | $57.14M | $5.3M | $462K | $1.04M | $1.67M |
| Net Debt | -$214.61M | -$112.75M | -$40.04M | -$33.88M | -$128.37M | -$103.22M | -$31M | -$114.61M | -$55.42M | -$8.36M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Operating Activities | ||||||||||
| Net Income | -$377.94M | -$246.29M | -$165.79M | -$134.5M | -$131.8M | -$86.48M | -$51M | -$49.33M | -$25M | -$16.21M |
| Depreciation & Amortization | $1.66M | $1.94M | $2.84M | $2.99M | $2.63M | $1.49M | $1.3M | $807K | $669K | $575K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $176K | $272K | -$199K | -$250K |
| Stock-Based Compensation | $75.6M | $36.63M | $27.14M | $27.7M | $23.15M | $11.18M | $7.97M | $5.21M | $1.48M | $556K |
| Changes in Working Capital: | ||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $25M | -$25M | $0 | $0 | $380K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$25.61M |
| Accounts Payable | $208K | $6.63M | -$529K | -$251K | $1.02M | $2.1M | -$1.34M | $1.66M | $636K | $91K |
| Other Working Capital | -$1.26M | -$36K | -$10.09M | -$34.14M | -$29.46M | -$15.86M | $5.18M | $66.23M | $832K | $25.49M |
| Total Working Capital Change | -$1.05M | $6.59M | -$10.61M | -$34.39M | -$28.44M | $11.24M | -$21.16M | $67.9M | $1.47M | $347K |
| Other Non-Cash Items | $1.7M | $186K | $1.19M | $5.51M | $7.67M | $2.3M | -$401K | -$289K | -$162K | -$162K |
| Net Cash from Operating | -$300.04M | -$200.95M | -$145.23M | -$132.69M | -$126.79M | -$60.27M | -$63.12M | $24.57M | -$21.74M | -$15.14M |
| Investing Activities | ||||||||||
| Capital Expenditures | -$602K | -$98K | -$71K | -$1.06M | -$5.25M | -$4.09M | -$3.12M | -$1.49M | -$361K | -$794K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$98.01M | -$293.16M | -$290.8M | -$300.63M | -$60.44M | -$200.11M | -$235.42M | -$75.24M | $0 | -$19.52M |
| Sales of Investments | $317.3M | $217.2M | $332M | $130M | $200M | $140.7M | $176.29M | $16.5M | $18.03M | $0 |
| Other Investing Activities | $0 | $0 | $13K | $0 | $0 | $0 | $8K | -$58.74M | $18.03M | -$19.52M |
| Net Cash from Investing | $218.69M | -$76.06M | $41.14M | -$171.7M | $134.31M | -$63.5M | -$62.24M | -$60.23M | $17.66M | -$20.32M |
| Financing Activities | ||||||||||
| Debt Repaid | -$49.14M | - | - | $975K | -$24.98M | -$24.62M | $365K | $667K | $667K | -$1M |
| Common Stock Issuance | $179.26M | $324.41M | $97.71M | $195.31M | $13.1M | $215.92M | $48.35M | $94.94M | $51.17M | $1.32M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $28.61M | $4.87M | $492K | $6.87M | $7.28M | $900K | $94.94M | $4.28M | $0 |
| Net Cash from Financing | $228.4M | $353.03M | $102.57M | $194.83M | $44.95M | $247.82M | $48.88M | $94.27M | $50.5M | $1M |
| Forex Effect | -$2K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $147.05M | $76.02M | -$1.51M | -$109.56M | $52.48M | $124.05M | -$76.47M | $58.61M | $46.43M | -$34.46M |
| Supplementary Data | ||||||||||
| Operating Cash Flow | -$300.04M | -$200.95M | -$145.23M | -$132.69M | -$126.79M | -$60.27M | -$63.12M | $24.57M | -$21.74M | -$15.14M |
| Capital Expenditure | -$602K | -$98K | -$71K | -$1.06M | -$5.25M | -$4.09M | -$3.12M | -$1.49M | -$361K | -$794K |
| Free Cash Flow | -$300.64M | -$201.05M | -$145.3M | -$133.76M | -$132.04M | -$64.36M | -$66.23M | $23.08M | -$22.1M | -$15.94M |
| Cash at Beginning | $180.28M | $104.26M | $105.77M | $215.33M | $162.86M | $38.81M | $115.27M | $56.67M | $10.24M | $44.7M |
| Cash at End | $327.33M | $180.28M | $104.26M | $105.77M | $215.33M | $162.86M | $38.81M | $115.27M | $56.67M | $10.24M |